Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antivirals.
Flisiak R, Zarębska-Michaluk D, Berak H, Dybowska D, Sitko M, Parfieniuk-Kowerda A, Janocha-Litwin J, Janczewska E, Piekarska A, Lorenc B, Mazur W, Dobrowolska K, Tudrujek-Zdunek M, Klapaczyński J, Jaroszewicz J.
Flisiak R, et al.
Clin Exp Hepatol. 2023 Sep;9(3):193-201. doi: 10.5114/ceh.2023.130935. Epub 2023 Sep 3.
Clin Exp Hepatol. 2023.
PMID: 37790681
Free PMC article.